Olivia Kaufmann
Overview
Olivia Kaufmann is a corporate healthcare associate in the New York office of Kirkland & Ellis LLP. She advises clients on a broad range of transactional and healthcare regulatory compliance matters. Olivia provides strategic transactional and healthcare regulatory compliance advice to physician and dental groups, health systems, pharmacies, and pharmaceutical and medical device manufacturers.
Olivia has extensive experience advising companies with FDA-regulated products, including food and beverages, pet food, dietary supplements and cosmetics. Olivia routinely evaluates FDA quality manufacturing and inspection compliance matters, product recalls, pre-market and post-market FDA requirements, in addition to FDA and FTC compliance requirements for product classification, product formulation and ingredients, labeling, marketing, advertising and claim substantiation. Olivia also has diverse experience advising clients on healthcare regulatory matters, including the corporate practice of medicine and professionals, state licensure requirements, and state and federal fraud and abuse laws.
Experience
Representative Matters
Healthcare Providers
- SK Capital in its investment in Spectrum Vascular, a provider of vascular access and medication management products
- Ascend Capital Partners in its acquisition of Unison Therapy Services
Food & Beverage
- One Equity Partners in its acquisition of CraftMark Bakery, a provider of bakery products for quick service restaurants and in-store retail bakeries, from CIC Partners
- BC Partners in its acquisition of PetLab Co., a provider of pet supplements
- Gryphon Investors in its acquisition of Spindrift Beverage Co., a provider of sparkling water, teas and lemonades, hard seltzers and mocktails
- Sycamore Partners in its acquisition of Playa Bowls, a super fruit bowl franchise restaurant, from Tamarix Equity Partners and Pacific General
- Clayton, Dubilier & Rice in its pending EUR 16 billion acquisition of Opella, a provider of over-the-counter drugs and vitamins, minerals and supplements, from Sanofi (XPAR: SAN; NASDAQ: SNY)
Life Sciences
- Franchise Group in its pending $193.5 million sale of The Vitamin Shoppe, a provider of vitamins and nutritional supplements, to Kingswood Capital Management and Performance Investment Partners
- Vyaire Medical in the sale of the Vyaire Respiratory Diagnostics (RDx) business unit, a manufacturer of respiratory diagnostic products, to Trudell Medical Limited
- Eli Lilly and Company (NYSE: LLY) in its $3.2 billion acquisition of Morphic (NASDAQ: MORF), a biotechnology company
- THL Partners in its investment in Red Nucleus, a provider of strategic services across the entire life sciences product cycle
- Waud Capital Partners in its acquisition of Science Exchange, a provider of life sciences procurement and supplier management SaaS solutions
- VSP Vision in its acquisition of Eyemart Express, a provider of eye care services and eyewear, from FFL Partners and Leonard Green & Partners
Prior Experience
More
Credentials
Admissions & Qualifications
- 2023New York
Education
- The George Washington University Law SchoolJ.D.2022
- University of MarylandB.S., Family Science & Criminology and Criminal Justicesumma cum laude2019